Copyright
©The Author(s) 2021.
World J Gastroenterol. Sep 28, 2021; 27(36): 6110-6127
Published online Sep 28, 2021. doi: 10.3748/wjg.v27.i36.6110
Published online Sep 28, 2021. doi: 10.3748/wjg.v27.i36.6110
Clinical characteristic | Value |
Age (mean ± SD) | 56.8 ± 8.65 |
Sex, n (%) | |
Male | 12 (20) |
Female | 3 (80) |
Histologic diagnosis, n (%) | |
EAC | 2 (13.3) |
ESCC | 13 (86.7) |
Cancer stage, n (%) | |
I-II | 4 (26.7) |
III-IV | 11 (73.3) |
TNM staging | |
Primary tumor (T) | |
T1 | 3 (20) |
T2 | 2 (13.3) |
T3 | 8 (53.4) |
T4 | 2 (13.3) |
Regional lymph nodes (N) | |
N0 | 4 (26.7) |
N1 | 6 (40) |
N2 | 3 (20) |
N3 | 2 (13.3) |
Distant metastases (M) | |
M0 | 12 (80) |
M1 | 3 (20) |
Alcohol history, n (%) | |
Yes | 8 (53) |
No | 7 (47) |
Smoking history, n (%) | |
Lifelong non-smoker | 1 (6.6) |
Current smoker | 7 (46.6) |
Current reformed smoker | 2 (13.3) |
Current reformed smoker for > 15 yr | 1 (6.6) |
NA | 4 (26.6) |
Age at starting smoking | |
Under 18 yr old | 6 (40) |
Over 18 yr old | 3 (20) |
NA | 6 (40) |
Pack-year smoked | |
Under 10 | 6 (40) |
Over 10 | 3 (20) |
NA | 6 (40) |
BMI (mean ± SD) | 20.8 ± 3.55 |
- Citation: Brancato V, Garbino N, Mannelli L, Aiello M, Salvatore M, Franzese M, Cavaliere C. Impact of radiogenomics in esophageal cancer on clinical outcomes: A pilot study. World J Gastroenterol 2021; 27(36): 6110-6127
- URL: https://www.wjgnet.com/1007-9327/full/v27/i36/6110.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i36.6110